TNG462: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 2 Phase 2 2

Condition	Trials
Pancreatic cancer	2
Breast cancer	1
Locally Advanced Solid Tumor	1
Lung Cancer	1
MTAP Deletion	1
NSCLC	1
PDAC	1
PDAC - Pancreatic Ductal Adenocarcinoma	1
Pancreatic Cancer Metastatic	1
RAS Mutation	1
Thoracic Cancer	1

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
NCT05732831 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 26 locations
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
NCT06922591 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations

2 recruiting trials across 11 conditions.

No. For the full record, search ClinicalTrials.gov.